SAN ANTONIO--(BUSINESS WIRE)--KCI, an Acelity Company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company’s De Novo request for the PREVENA™ Incision Management ...
SAN ANTONIO--(BUSINESS WIRE)--Acelity, a global advanced wound care company, today announced that the PREVENA DUO™ Incision Management System is now available to physicians in the United States. The ...
Please provide your email address to receive an email when new articles are posted on . According to study results, patients who underwent direct-anterior approach total hip arthroplasty and had ...
In December 2025, Solventum announced updated consensus recommendations from an international panel on the clinical use of closed incision negative pressure therapy (ciNPT) with its proprietary ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Use of closed-incision negative pressure therapy had no significant difference in wound complication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results